Skip to main content
Clinical Trials/NCT05366777
NCT05366777
Completed
Not Applicable

Effect of an Intravenous Acetaminophen/Ibuprofen Fixed-dose Combination on Postoperative Opioid Consumption and Pain After Video-assisted Thoracic Surgery: A Double-blind Randomized Controlled Trial

Seoul National University Hospital1 site in 1 country96 target enrollmentOctober 3, 2022

Overview

Phase
Not Applicable
Intervention
acetaminophen/ibuprofen fixed-dose combination
Conditions
Postoperative Pain
Sponsor
Seoul National University Hospital
Enrollment
96
Locations
1
Primary Endpoint
Total fentanyl consumption during 24 hours
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This prospective, randomized, double-blinded study is designed to evaluate the postoperative analgesic effect of the intravenous acetaminophen/ibuprofen fixed-dose combination in patients undergoing video-assisted thoracic surgery (VATS). We hypothesize that the intravenous acetaminophen/ibuprofen fixed-dose combination can significantly reduce postoperative opioid consumption and pain severity in patients with VATS.

Detailed Description

Adult patients undergoing elective unilateral VATS wedge resection, segmentectomy, or lobectomy are randomly allocated to receive intravenous acetaminophen (1000 mg)/ibuprofen (300 mg) fixed-dose combination (n=48) or not (n=48). At the end of induction, the intervention group will receive intravenous acetaminophen (1000 mg)/ibuprofen (300 mg) for 15 min, every 6 hours, a total of 4 times. The control group will receive intravenous normal saline with the same volume and same time points as the intervention group receives.

Registry
clinicaltrials.gov
Start Date
October 3, 2022
End Date
October 15, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hojin Lee, MD

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled to undergo elective unilateral VATS segmentectomy or lobectomy under general anesthesia
  • American Society of Anesthesiologists (ASA)physical classification I-II
  • Consent to IV-patient controlled analgesia use
  • Willingness and ability to sign an informed consent document

Exclusion Criteria

  • Do not understand our study
  • Allergies to anesthetic or analgesic medications
  • Continuous local anesthetics infiltration for postoperative pain control
  • Patients who receive mechanical ventilation more than 2 hours after surgery
  • Pregnancy/Breastfeeder
  • Medical or psychological disease that can affect thetreatment response

Arms & Interventions

Maxigesic group

At the end of induction, the Maxigesic group will receive intravenous acetaminophen (1000 mg)/ibuprofen (300 mg) for 15 min, every 6 hours, a total of 4 times.

Intervention: acetaminophen/ibuprofen fixed-dose combination

Control group

At the end of induction, the control group will receive intravenous normal saline with the same volume and same time points as the intervention group receives.

Intervention: Saline

Outcomes

Primary Outcomes

Total fentanyl consumption during 24 hours

Time Frame: postoperative 24 hours

postoperative fentanyl consumption (mcg) via IV patient controlled analgesia

Secondary Outcomes

  • Total fentanyl consumption(postoperative 6, 48 hours)
  • Postoperative nausea and vomiting(postoperative 24, 48 hours)
  • Postoperative pain score(postoperative 6, 24, 48 hours)
  • Quality of recovery-15(postoperative 24, 48 hours)

Study Sites (1)

Loading locations...

Similar Trials